Loading...
XNYS
EHC
Market cap11bUSD
Jul 08, Last price  
118.13USD
1D
-1.06%
1Q
14.47%
Jan 2017
186.45%
Name

Encompass Health Corp

Chart & Performance

D1W1MN
P/E
26.13
P/S
2.22
EPS
4.52
Div Yield, %
0.52%
Shrs. gr., 5y
0.56%
Rev. gr., 5y
3.13%
Revenues
5.37b
+11.91%
3,207,728,0003,000,100,0001,752,500,0001,842,400,0001,911,100,000520,700,0002,026,900,0002,134,900,0002,247,200,0002,374,300,0003,115,700,0003,646,000,0003,919,000,0004,277,300,0004,605,000,0004,644,400,0005,121,600,0004,348,600,0004,801,200,0005,373,200,000
Net income
456m
+29.46%
-445,994,000-625,000,000653,400,000252,400,00094,800,000779,200,000208,700,000185,000,000323,600,000222,000,000183,100,000247,600,000256,300,000292,300,000358,700,000284,200,000412,200,000271,000,000352,000,000455,700,000
CFO
-3m
L
1,561,000-120,400,000230,700,000227,200,000406,100,000331,000,000342,700,000411,500,000470,300,000444,900,000484,800,000605,500,000657,200,000762,400,000635,300,000704,700,000715,800,000705,800,000850,800,000-3,100,000
Dividend
Jan 02, 20250.17 USD/sh
Earnings
Aug 04, 2025

Profile

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
URL
https://www.encompasshealth.com/
IPO date
Sep 24, 1986
Employees
36,900
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
5,373,200
11.91%
4,801,200
10.41%
4,348,600
-15.09%
Cost of revenue
3,110,200
4,069,400
2,804,400
Unusual Expense (Income)
NOPBT
2,263,000
731,800
1,544,200
NOPBT Margin
42.12%
15.24%
35.51%
Operating Taxes
150,200
132,200
100,100
Tax Rate
6.64%
18.07%
6.48%
NOPAT
2,112,800
599,600
1,444,100
Net income
455,700
29.46%
352,000
29.89%
271,000
-34.26%
Dividends
(62,800)
(60,400)
(99,000)
Dividend yield
0.67%
0.89%
1.65%
Proceeds from repurchase of equity
(31,100)
(8,200)
BB yield
0.33%
0.12%
Debt
Debt current
164,900
48,900
50,800
Long-term debt
405,700
3,076,100
3,166,800
Deferred revenue
28,000
Other long-term liabilities
2,549,600
205,900
174,200
Net debt
485,200
2,946,400
3,043,400
Cash flow
Cash from operating activities
(3,100)
850,800
705,800
CAPEX
(642,500)
(583,100)
(584,100)
Cash from investing activities
(653,300)
(602,800)
(627,000)
Cash from financing activities
(330,600)
(197,200)
(145,700)
FCF
1,772,700
289,500
1,164,700
Balance
Cash
85,400
69,100
21,800
Long term investments
109,500
152,400
Excess cash
Stockholders' equity
854,400
1,057,400
668,400
Invested Capital
5,753,400
5,365,300
5,028,400
ROIC
38.00%
11.54%
25.93%
ROCE
38.63%
13.42%
30.21%
EV
Common stock shares outstanding
102,200
101,300
100,400
Price
92.35
38.41%
66.72
11.55%
59.81
-8.35%
Market cap
9,438,170
39.64%
6,758,736
12.55%
6,004,924
-8.17%
EV
9,979,870
10,354,836
9,599,924
EBITDA
2,562,600
1,005,700
1,787,800
EV/EBITDA
3.89
10.30
5.37
Interest
137,400
143,500
175,700
Interest/NOPBT
6.07%
19.61%
11.38%